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The SMN complex mediates the assembly of hepta-
meric Sm protein rings on small nuclear RNAs
(snRNAs), which are essential for snRNP function.
Specific Sm core assembly depends on Sm proteins
and snRNA recognition by SMN/Gemin2- and
Gemin5-containing subunits, respectively. The
mechanism by which the Sm proteins are gathered
while preventing illicit Sm assembly on non-snRNAs
is unknown. Here, we describe the 2.5 A˚ crystal
structure of Gemin2 bound to SmD1/D2/F/E/G pen-
tamer and SMN’s Gemin2-binding domain, a key
assembly intermediate. Remarkably, through its
extended conformation, Gemin2 wraps around the
crescent-shaped pentamer, interacting with all five
Sm proteins, and gripping its bottom and top sides
and outer perimeter. Gemin2 reaches into the RNA-
binding pocket, preventing RNA binding. Interest-
ingly, SMN-Gemin2 interaction is abrogated by
a spinal muscular atrophy (SMA)-causing mutation
in an SMN helix that mediates Gemin2 binding. These
findings provide insight into SMN complex assembly
and specificity, linking snRNP biogenesis and SMA
pathogenesis.INTRODUCTION
Small nuclear ribonucleoprotein particles (snRNPs) are a major
class of noncoding RNA-protein complexes that play key roles
in posttranscriptional gene expression, including pre-messenger
RNA (pre-mRNA) splicing and suppression of premature
termination (Kaida et al., 2010; Staley and Guthrie, 1998; Wahl
et al., 2009). Each snRNP consists of one 100–200 nucleotide
small nuclear RNA (snRNA), called U1, U2, U4, U5, U11, U12,
and U4atac, and a heptameric ring of Sm proteins (B/B0, D1,
D2, D3, E, F, and G) that surrounds the snRNA’s Sm site
(Sm core), as well as several proteins specific to each U snRNA384 Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc.(Kambach et al., 1999; Newman and Nagai, 2010; Patel and
Steitz, 2003; Pomeranz Krummel et al., 2009; Weber et al.,
2010; Will and Lu¨hrmann, 2001). Sm cores are essential for the
function, stability, and nuclear localization of snRNPs, and their
assembly is a key step in snRNP biogenesis (Mattaj et al.,
1993; Will and Lu¨hrmann, 2001). In vitro, purified Sm proteins
can spontaneously form Sm cores on any RNA or oligoribonu-
cleotide that contains a sequence resembling an Sm site,
AUUUUUG or AUUUGUG (Raker et al., 1999). This assembly
occurs stepwise from three Sm heteromeric subcore com-
plexes, SmD1/D2, SmF/E/G, and SmB/D3. SmD1/D2 and
SmF/E/G first associate, forming a pentameric subcore that
avidly binds RNA and this subsequently recruits SmB/D3,
completing the formation of a highly stable Sm core (Raker
et al., 1996). However, as sequences on which Sm proteins
have the propensity to assemble do not uniquely define snRNAs
(Pellizzoni et al., 2002b), in cells potentially deleterious illicit Sm
core assembly is prevented by the SMN complex, a molecular
assembly machine that confers the necessary stringent speci-
ficity, ensuring Sm core assembly only on snRNAs (Fischer
et al., 1997; Liu et al., 1997; Meister et al., 2001a; Pellizzoni
et al., 2002b).
The SMN complex is comprised of SMN, Gemins 2-8, and
Unrip (Baccon et al., 2002; Carissimi et al., 2005, 2006; Charroux
et al., 1999, 2000; Grimmler et al., 2005; Gubitz et al., 2002; Liu
et al., 1997; Pellizzoni et al., 2002a). Recent findings showed
that the active SMN complex, comprised of all of its known
components, is made up of distinct subunits (Battle et al.,
2007; Carissimi et al., 2005, 2006; Chari et al., 2008; Yong
et al., 2010). The Sm proteins are recognized by a subunit that
includes SMN and Gemin2 (Chari et al., 2008; Yong et al.,
2010). The specificity for snRNAs is determined separately by
Gemin5 (Battle et al., 2006; Lau et al., 2009), which recognizes
a large 50–60 nucleotide structure, called the snRNP code,
that includes the Sm site and an adjacent 30-terminal stem-
loop structure found in all the pre-snRNAs and distinguishing
them from other classes of RNAs (Golembe et al., 2005; Yong
et al., 2004a, 2010). Additional subunits, one containing Gemins
6/7/8 and Unrip that can interact with SMN/Gemin2, and another
comprised of the putative RNA helicase Gemin3 that can interact
with Gemin4 and Gemin5, are also required for Sm core
Figure 1. Gemin2 Binds the Sm Pentamer,
D1, D2, E, F, and G
Recombinant GST-SMN or GST-SMN/Gemin2
was used for the binding to recombinant Sm
proteins (left). Similarly, in a separate experiment,
recombinant GST-Gemin2 or GST-Gemin2 with C
terminus-truncated SMN (residues 1–194) was
used for the binding to Sm proteins (right). Either
individual subcore complex (SmD1/D2, SmF/E/G,
or SmB/D3) or the five (SmD1/D2/F/E/G) or all
seven Sm proteins (SmD1/D2/F/E/G/B/D3) were
used in binding. For efficient expression, SmB/D3
proteins do not contain their C-terminal RG-rich
domain. The asterisk indicates degradation prod-
ucts of GST-Gemin2. The total panel shows 5% of
the proteins used for binding.assembly in complex eukaryotes, but their specific functions are
not yet known (Battle et al., 2007; Carissimi et al., 2006; Yong
et al., 2010). Despite significant advances, essential details on
the process by which specific Sm core assembly is achieved in
cells remain to be defined, and a lack of atomic resolution struc-
ture of SMN complex components has limited progress on its
mechanism and function. To date, only the structures of one
domain in SMN, the Tudor domain (Selenko et al., 2001;
Sprangers et al., 2003), and of a Gemins 6/7 heterodimer (Ma
et al., 2005) have been described.
Here, we identified Gemin2 as the protein that binds a pen-
tamer of Sm proteins comprised of SmD1/D2 and SmF/E/G.
We determined the crystal structure of this complex bound to
SMN’s Gemin2 binding domain to 2.5 A˚, providing important
mechanistic insights for SMN complex function and on Sm
core assembly. An additional dimension of interest in the SMN
complex and the snRNP assembly pathway comes from the
fact that reduced levels of functional SMN, due to protein defi-
ciency (>97% of the cases) or loss of function mutations, cause
spinal muscular atrophy (SMA), a commonmotor neuron degen-
erative disease and a leading hereditary cause of infant mortality
(Lefebvre et al., 1995; Talbot and Davies, 2001; Wirth et al.,
2006). Information from the structure we determined explains
the molecular basis of an SMA-causing patient mutation in
SMN, linking a defect in Gemin2-mediated Sm pentamer recruit-
ment to SMA.
RESULTS
Gemin2 Binds a Pentamer of Sm Proteins,
D1, D2, E, F, and G
Previous studies identified subunits of the SMN complex,
including a key intermediate containing SMN, Gemin2, and
a subset of Sm proteins in human cells (Battle et al., 2007;
Carissimi et al., 2005, 2006; Chari et al., 2008; Yong et al.,
2010). SMN andGemin2, also known as SMN-interacting protein
1 (SIP1) (Liu et al., 1997), exist as a heterodimer that further oli-Cell 146, 384–39gomerizes via SMN’s C-terminal YG
domain (Pellizzoni et al., 1999). To define
interactions of SMN and Gemin2 with Sm
proteins, we performed in vitro bindingexperiments using recombinant SMN, Gemin2 with all the Sm
proteins, coexpressed according to their known heteromeric
interactions, SmD1/D2, SmF/E/G, and SmB/D3 (Kambach
et al., 1999; Raker et al., 1996). Binding assays with the purified
proteins showed that SMN/Gemin2 bound to SmD1/D2 and
SmF/E/G together, but little or no binding was detected to either
of these alone (Figure 1), suggesting that SMN/Gemin2 binds to
a pentamer that these di- and triheteromeric Sm protein
complexes can form (Raker et al., 1996). No binding to SmB/
D3 was detected under these conditions. SmB/D3 was previ-
ously shown to interact with SMN, dependent on posttransla-
tional arginine methylation of their RG-rich domains (Brahms
et al., 2001; Friesen and Dreyfuss, 2000; Friesen et al., 2001a),
which for efficiency of expression were not included in our
constructs. Surprisingly, deletions of most of SMN, leaving
only SMN’s Gemin2 binding domain (SMNGe2BD; SMN residues
26–62) (Liu et al., 1997; Wang and Dreyfuss, 2001), showed
similar Sm pentamer binding, indicating that most of SMN is
not necessary for this interaction (Figure 1 and data not shown).
Indeed, Gemin2 alone could bind the Sm pentamer with similar
efficiency to that of SMN/Gemin2 (Figure 1).
Determination of the Crystal Structure
of Gemin2-SMNGe2BD-Sm Pentamer
The structure of an SMN complex intermediate that contains the
majority of the Sm proteins is critical for understanding the Sm
core assembly process, and we therefore set out crystallization
trials of SMN/Gemin2 with SmD1/D2 and SmF/E/G. Attempts
to obtain crystals containing full-length SMN were not success-
ful. However, a complex containing Gemin2, SMNGe2BD, and the
Sm pentamer migrated as a single peak in gel filtration and
yielded well diffracting crystals. The structure of human
SmD1/D2 dimer was previously determined to 2.5 A˚ (Kambach
et al., 1999). In addition, the structures of human SmB/D3 as
well as bacterial and archeal Sm-like proteins were determined
to high resolution (Collins et al., 2003; Kambach et al., 1999;
Sauter et al., 2003; To¨ro¨ et al., 2001), and we used them to build5, August 5, 2011 ª2011 Elsevier Inc. 385
Table 1. Data Collection and Refinement Statistics
Data Collection
Data set Native Se-Met derivative
Wavelength (A˚) 0.99993 0.9791
Space group P212121 P212121
Unit cell dimensions (A˚) a = 82.83,
b = 84.60,
c = 104.66
a = 82.90,
b = 86.56,
c = 105.03
Highest resolution (A˚)
a*, b*, and c*
2.4, 3.2, 2.6 3.0, 4.0, 3.0
Unique reflections 19831 11688
Completeness (%) 99.3 (98.6)a 98.1 (98.3)d
76.0 (20.0)b 75.2 (25.1)e
Rsym(%) 0.124 (0.284)
c 0.182(0.217)f
Mean I/s 13.7 (3.8) 7.6 (4.3)
Redundancy 6.3 (3.8) 7.7 (5.1)
Refinement Statistics
Resolution range for
refinement (A˚)
40–2.5
R factor (%) 25.7
Rfree factor (%) 33.1
Number of reflections 19831
Number of protein atoms 4554
Number of water molecules 33
Rmsd bond lengths (A˚) 0.014
Rmsd bond angles (o) 1.64
Ramachandran plot (%)
Favored, additional allowed,
disallowed
92.3, 6.4, 1.3
Rsym = S jI – <I>j / S I, where I is the observed intensity and <I> is
the average intensity from multiple measurements. R factor = S jFobs –
Fcalcj / S Fobs. For recalculation of Rfree, 5.1% of the truncated data set
was excluded from the refinement.
a For resolution range of 40–3.2 A˚, the number in parenthesis corre-
sponds to the highest-resolution shell of 3.35–3.20 A˚.
b For resolution range of 40–2.5 A˚, the number in parenthesis corre-
sponds to the highest-resolution shell of 2.62–2.50 A˚. Before ellipsoidal
truncation of the data, the completeness is 98.8% (95.2% in the high-
est-resolution shell).
c The number in parenthesis corresponds to the highest-resolution shell
of 3.35–3.20 A˚, which was unaffected by ellipsoidal truncation. The
Rsym of the resolution range 3.2–2.4 A˚ was not obtained as a result of
anisotropic diffraction. We performed ellipsoidal truncation on the
merged data set.
d For resolution range of 40–4.0 A˚, the number in parenthesis corre-
sponds to the highest-resolution shell of 4.2–4.0 A˚.
e For resolution range of 40–3.0 A˚, the number in parenthesis corre-
sponds to the highest-resolution shell of 3.16–3.00 A˚. Before ellipsoidal
truncation of the data, the completeness is 98.1% (84.7% in the high-
est-resolution shell).
f The number in parenthesis corresponds to the highest-resolution shell of
4.2–4.0 A˚, which was unaffected by ellipsoidal truncation. The Rsym of the
resolution range 4.0–3.0 A˚ was not obtained as a result of anisotropic
diffraction. We performed ellipsoidal truncation on the merged data set.structure models of SmF, E, and G. Using SmD1/D2 and SmF/E/
G models for molecular replacement in combination with single-
wavelength anomalous diffraction (SAD) phasing from seleno-
methionine (Se-met) labeling in Gemin2 and SmF, E, and G, we
solved the structure of this seven-component complex to 2.5 A˚
resolution (Table 1).
The final refined model of Gemin2-SMNGe2BD-Sm pentamer
(PDB ID code 3S6N) is shown in Figure 2. Overall, the five Sm
proteins in the complex are arranged as a crescent-shaped
five-sevenths of a ring. The arrangement of the Sm proteins in
the pentamer, as SmD1, D2, F, E, and G, clockwise from a top
view (Figure 2A), is the same as in Sm cores visualized in struc-
tures of U1 snRNP (Pomeranz Krummel et al., 2009;Weber et al.,
2010) (Figure S1A available online). Consistent with the binding
experiments (Figure 1), Gemin2 contacts the Sm pentamer.
Gemin2 has an extended conformation, wrapping around the
Sm pentamer and interacting with both SmD1/D2 and SmF/E/G
via two distinct structural domains. Gemin2’s C-terminal domain
(residues 100–280) interacts with both SmD1/D2 and with
SMNGe2BD on opposite distal surfaces, while its N-terminal
domain (residues 1–69) interacts with SmF/E/G. SMNGe2BD
comprises a single helix (residues 37–51) that does not contact
the Sm pentamer (Figure 2).
Structure of the Sm Proteins
in the Gemin2-SMNGe2BD-Sm Pentamer
Each of the Smproteins in the pentamer has a canonical Sm fold,
consisting of an N-terminal a helix followed by a strongly bent
five-stranded antiparallel b sheet with loops connecting each
of these segments (Kambach et al., 1999) (Figure S1A). In addi-
tion to the 2.5 A˚ SmD1/D2 structure (Kambach et al., 1999), two
recently published structures of assembled human Sm cores,
a 5.5 A˚ structure of U1 snRNP reconstituted from recombinant
proteins (Pomeranz Krummel et al., 2009) and a 4.4 A˚ structure
of lightly protease-digested native U1 snRNP purified from
HeLa cells (Weber et al., 2010), provided useful references
against which the structure of the Sm proteins in our complex
could be compared. The SmD1/D2 structure in our complex is
very similar to the 2.5 A˚ dimer structure (rmsd of 0.39 A˚ for
all the equivalent main-chain atoms), and the Ca trace for
SmF/E/G is very similar to that of the corresponding proteins in
the U1 snRNP at 4.4 A˚ (rmsd 1.16 A˚), demonstrating an overall
similarity of Sm proteins’ folds and arrangement in all contexts
(Figure S1B).
Our structure revealed several differences and details on
Sm protein organizations that were not observed in previous
structures. In our complex, more residues in SmD2 are visible
and certain loop regions and C-terminal tail of SmD2 and
SmD1 adopt slightly different conformations (Figure S1B),
probably because of their contact with SmF/E/G as well as
with Gemin2. Our structure also provides a view of the inter-
molecular interactions between neighboring Sm proteins in
the pentamer, including the interactions within the SmF/E/G
subcore complex as well as at the SmD2-SmF interface that
connects the two Sm subcore complexes (see details in
Figure S1).
Notably, the Gemin2-bound Sm pentamer has a narrower
conformation compared to that in the assembled, snRNA-bound386 Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc.
Figure 2. Overall Structure of the Gemin2-SMNGe2BD-Sm Pentamer Complex
Four rotational views of the ribbon diagram of the complex structure (PDB ID code 3S6N) are shown with the surface representation. The five Sm proteins, SmD1,
D2, F, E, and G, are colored in lime, lemon, pink, dark green, and orange, respectively. Gemin2 and SMNGe2BD peptide are colored in red and blue, respectively.
Gemin2’s domains and secondary structures are labeled. In (A), the five Sm proteins are arranged in the clockwise order of SmD1, D2, F, E, and G to form five-
sevenths of a doughnut shape with their canonical N-terminal helices facing out. The structure contains visible structures of SmD1 (residues 1–81), SmD2
(residues 23–76 and 90–116), SmF (residues 3–76), SmE (residues 14–90), SmG (residues 14–51 and 56–72), Gemin2 (residues 22–31, 47–69, 83–123, 134–149,
and 179–276), and SMN (residues 37–51). The disordered loop connecting the N-terminal tail and a1 of Gemin2 is shown in a red dashed line in (A). The disordered
loop connecting the N- and C-terminal domains of Gemin2 is also shown with red dashed lines in (A), (B), and (D). The figures are prepared with PyMOL (The
PyMOLMolecular Graphics System, Version 1.3, Schro¨dinger). The rotation of the views is indicated by arrow and the degree of the rotation. See also Figures S1
and Figure S2.Sm core of U1 snRNP (Weber et al., 2010). While individual Sm
proteins in the two structures show little deviations (rmsd of
0.67, 0.89, 0.71, 0.79, and 0.90 A˚ for SmD1, D2, F, E, and G,
respectively), comparison of the entire Sm pentamer from the
two structures shows significant differences. As shown in Fig-
ure S2A, when the Ca of SmD1/D2 in the two structures are
superimposed (0.78 A˚ rmsd), SmF/E/G comparison gives a
5.81 A˚ rmsd on average (3.13, 5.90, and 8.07 A˚ rmsd for
SmF, E, and G, respectively). Similarly, when SmF/E/G coordi-
nates are aligned (1.16 A˚ rmsd), SmD1/D2 deviates by 4.70 A˚
(5.85 and 3.05 A˚ rmsd for SmD1 and D2, respectively) (Fig-
ure S2B). As a result, the width of the opening between SmD1
and SmG in Gemin2-bound Sm pentamer is smaller than in the
assembled Sm core. For example, the distance between themost conserved residues of the pentamer, SmD1 Asn37 to
SmG Asn39 is 27.4 A˚ in our structure versus 31.2 A˚ in the U1
snRNP structure (Figure S2C). There is also a smaller angle
between SmD1 Asn37, SmF Asn41, and SmG Asn39 (64.9
versus 76.2) (Figure S2C). Consequently, the space between
SmD1 and SmG is not sufficient for SmB/D3 to fit in and the
pentamer’s RNA-binding pocket could not accommodate
the snRNA’s Sm site (Figure S2D, and see below in Figure 4D),
at least not in the conformation it has based on the U1
snRNP model (Weber et al., 2010). These findings suggest that
although the interfaces within each of the Sm subcore
complexes, SmD1/D2 and SmF/E/G, are rigid, there is consider-
able angular flexibility at the SmD2-SmF interface that may be
utilized during Sm core assembly.Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc. 387
Figure 3. Multiple Sequence Alignment of
Gemin2 Orthologs from Diverse Organisms
The sequence alignment was performed with
the Praline program (Simossis and Heringa,
2005). Human, Homo sapiens (accession
number NP_003607); mouse, Mus musculus
(NP_079932); chicken, Gallus gallus (NP_989530);
zebrafish, Danio rerio (NP_001017608); hydra,
Hydra magnipapillata (XP_002160350); S. pombe,
Schizosaccharomyces pombe (CAB88094). Con-
servation of sequence is represented based on the
BLOSUM score matrix. Partially conserved resi-
dues (conservation score 4–7) are highlighted as
light gray; highly conserved residues (conserva-
tion score 8–10) are highlighted as dark gray.
Gemin2’s secondary structure, as seen in the
crystal, is indicated with red boxes for a helices,
blue box for the b sheet, and green lines for the
loops. Positions of the mutations (Tyr52 and
Arg213) are indicated by arrows.Structure of Gemin2 and Its Interactions
with the Sm Pentamer
The contact between Gemin2 and the Sm pentamer is remark-
ably extensive, encompassing a large combined buried area
(total 5130 A˚2). Gemin2’s C- (residues 100–280) and N-terminal
(residues 1–69) domains interact with SmD1/D2 and SmF/E,
respectively. A relatively unstructured loop 1 (residues 70–99)
connects these two domains and surrounds the perimeter of
SmD2/F. Additionally, Gemin2’s N-terminal tail (residues 1–46)
extends into the inner RNA-binding pocket of the Sm pentamer
(Figure 2). These extensive contacts between Gemin2 and the
Sm pentamer, supported by high-quality electron density
maps (Figure S3), reveal how Gemin2 could stabilize the pen-
tamer, which by itself is relatively unstable (Raker et al., 1996),
and is consistent with Gemin2’s strong binding to the pentamer
compared to either SmD1/D2 or SmF/E/G alone (Figure 1).
Multiple sequence alignment of Gemin2 orthologs from diver-
gent eukaryotic organisms shows a high degree of amino acid
sequence aswell as secondary structure conservation (Figure 3).
In accord with Gemin2’s structure, the highest conservation is
observed for a1 and b1 in the N-terminal domain and the helices
of the C-terminal domain.
Gemin2’s C-terminal domain consists of seven a helices (Fig-
ure 2). As shown in a model in Figure 4A that is supported by
the electron density map in Figure S3A, helices a5–8 (residues
187–271) form an antiparallel four-helix bundle, and a2 (residues
100–122) is a long orthogonal helix packed against a6 and a8.
Between the two well-structured segments, there are two short
helices (a3–a4) and two invisible loops: one between a2 and a3
and the other between a3 and a4. The four-helix bundle and a2
account for the entire binding surface to SmD1/D2 as well as
most of the binding surface to SMNGe2BD. The interactions
between Gemin2 and SmD1/D2 mainly involve polar networks
between loop 4, 6 of Gemin2 and b3–b4 of SmD1, as well
as between a7 of Gemin2 and b3–b4 of SmD2. The main chain388 Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc.of Gln188 (loop 4) and Pro225 (loop 6) in Gemin2 form hydrogen
bonds with Glu51 and Thr46 in SmD1, respectively. In addition,
the side chain of Glu223 and carbonyl group of Lys224 from
loop 6 of Gemin2 form salt bridges with Lys44 of SmD1.
Ser232, Arg235, and Arg239, which are highly conserved among
Gemin2 orthologs, make extensive hydrophilic network with
a water molecule and Asp93 from SmD2. Moreover, His231 of
Gemin2 forms hydrogen bonds with Arg94 of SmD2 (Figure 4A).
Connecting the N- andC-terminal domains of Gemin2 is loop 1
(residues 70–99), whose second half (residues 83–99) interacts
with SmD2. Although its first half (residues 70–82) is invisible in
our structure, its trajectory and length suggest that this segment
loosely wraps around the perimeter of SmD2/F (Figure 2). The
amino acid sequence of this loop varies among Gemin2 ortho-
logs of divergent organisms; however, its length in all exceeds
22 residues (Figure 3), which is sufficient to cover the distance
between the N- and C-terminal domains of Gemin2.
Gemin2’s N-terminal domain contains a single a helix (a1),
which mainly contacts SmF/E, followed by a short sequence
(VVVA), which forms a b strand that pairs with the b sheet of
SmF (Figures 4B and 4C and Figures S3B and S3C). a1 of
Gemin2 contains a highly conserved YLxxVxxE motif (Figure 3),
of which the conserved residues Tyr52, Leu53, and Val56 form
a hydrophobic patch and contact the hydrophobic surface
formed by Ile18, Phe22, Leu25, and Phe50 of SmE (Figure 4B).
In addition, the interactions between Gemin2’s a1 and SmF/E
are substantiated through an extensive hydrogen-bonding
network involving the side chains of Tyr52 and Glu59 in Gemin2,
side chain of Asn6 in SmF, andmain-chain amide group of Phe50
in SmE. This network is further extended to the main chain
carbonyl group of Val56 in Gemin2’s a1 via a well-defined water
molecule (Figure 4B). Consistently, Gemin2’s interacting resi-
dues in SmE (Ile18, Phe22, Leu25, and Phe50) and in SmF
(Asn6) are also highly conserved (Weber et al., 2010). These find-
ings indicate a functional significance of these interactions,
Figure 4. Detailed Views of Gemin2 Structure and Its Interactions with the Sm Pentamer
Ribbons are colored as in Figure 2. Amino acid residues involved in the interactions as described in the text are shown in sticks (A–C) or spheres (D). Side-chain
carbon atoms are labeled in the same color as their respective protein chains. Oxygen and nitrogen are colored in red and blue, respectively. Potential hydrogen
bonds and salt bridges are shown as dashed lines. Water molecules are shown as red spheres.
(A) Interactions between Gemin2’s C-terminal domain and SmD1/D2.
(B) Interactions between a1 of Gemin2 and SmF/E.
(C) Interactions between b1 of Gemin2 and b2 of SmF.
(D) Gemin2’s N-terminal tail inserts into the Sm pentamer’s RNA-binding pocket and interacts with the five Sm proteins. The five amino acids shown in blue
spheres, Ser35, His62, Tyr39, Tyr53, and Phe32 in Sm D1, D2, F, E, and G, respectively, are involved in the interactions with RNA by stacking nucleotide bases
from the top. Gemin2’s Leu24, Met25, and Leu28 block the RNA nucleotide binding pockets of SmF, E, and G, respectively.
See also Figure S3.which is further supported by mutagenesis studies on one of the
critical residues, Tyr52 (see below in Figure 5). The short b strand
following a1 of Gemin2 pairs with the second half of b2 of SmF
through antiparallel b sheet interactions (Figure 4C). These inter-
actions are further enhanced by additional hydrogen bondings:
between the main chain of Val67 of Gemin2 and the side chain
of Ser35 of SmF, between carbonyl oxygen of Asp65 in Gemin2
and the side chain of Lys8 in SmF, and between the side chain of
Asp65 in Gemin2 and main chain of Gly38 in SmF mediated by
a water molecule (Figure 4C).
The RNA-interacting residues of Sm proteins are highly
conserved among archaeal and eukaryotic Sm and Sm-like
proteins. The crystal structures of two archaeal Sm protein
homoheptamers complexed with oligo(U) RNA reveal how
each Sm protein contacts each uracil (Thore et al., 2003; To¨ro¨
et al., 2001). Based on this insight and biochemical studies,
Weber and colleagues provided a similar interaction model, in
which each Sm protein provides one aromatic residue on the
top and one positively charged residue at the bottom to sand-
wich each base while simultaneously using the most conserved
residue among Sm proteins, Asn, to form hydrogen bonds withthe base from the side (Weber et al., 2010). Strikingly, however,
in our structure the N-terminal tail of Gemin2 occludes the RNA-
binding surface of the Sm pentamer and extensively overlaps
with the positions of the U1 snRNA’s Sm site in the pocket.
Gemin2’s N-terminal residues 22–31 extend into the center of
the Sm pentamer’s RNA-binding pocket, contacting most of
the base-binding sites. Specifically, the electron density map
shows that Gemin2’s Leu24, Met25, and Leu28 are right at the
base-binding pocket (Figure 4D and Figure S3D). This result
suggests that Gemin2 would interfere with the Sm pentamer’s
binding to snRNA.
Gemin2 Inhibits the Sm Pentamer from Binding RNA
To test the effect of Gemin2 on the Sm pentamer’s snRNA
binding as predicted from the structure, we measured the
binding of the Sm pentamer to [32P]-a-UTP labeled U4 or
U4DSm snRNA in the absence or presence of Gemin2 and its
various mutants by electrophoretic mobility shift (Raker et al.,
1999). The Sm pentamer bound efficiently to U4 but not to
U4DSm, indicating that it forms an RNP dependent on the nucle-
otides present in an Sm site (Figure 5A). Importantly, Gemin2Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc. 389
Figure 5. Gemin2 Prevents the Sm Pen-
tamer from Binding RNA
(A) Gemin2 dose-dependently inhibits the Sm
pentamer from binding RNA and its N terminus is
critical for this inhibition. Gemin2 or Gemin2DN39
(1 mg) copurified with GST-SMNGe2BD was pre-
incubated with increasing amounts of the five Sm
proteins (D1/D2/F/E/G; 10–50 ng of each) and then
assayed for binding to [32P]-a-UTP labeled U4 or
U4DSm snRNA. SmD1/D2 or SmF/E/G were used
as controls (left). In a parallel experiment, SmD1/
D2/F/E/G was preincubated with increasing
amounts (1–9 mg) of Gemin2 or Gemin2DN39 that
were copurified with GST-SMNGe2BD and assayed
for RNA binding. The positions of the free RNA and
the Sm pentamers assembled on the RNA are
indicated.
(B) The effects of wild-type or various mutant
Gemin2 proteins on the Sm pentamer’s binding to
RNA. Increasing amounts (1–9 mg) of GST,
GST-Gemin2 wild-type (WT), or various GST
tagged Gemin2 mutants (Y52D and R213D) were
preincubated with SmD1/D2/F/E/G and assayed
for binding to U4 snRNA as in (A).
(C) Protein binding between wild-type or various
Gemin2 mutants and the Sm pentamer. Re-
combinant wild-type and mutant Gemin2 proteins
(2.5–5 mg) used in (A) and (B) were assayed for
binding to SmD1/D2/F/E/G (1 mg). The total panel
shows 5% of the proteins used for binding.inhibited the pentamer’s binding to U4 in a dose-dependent
manner (Figures 5A and 5B). This inhibition is dependent on
direct binding of Gemin2 to the pentamer, as the mutation of
a highly conserved Gemin2 residue Tyr52 (Y52D) (Figures 3
and 4B) impairs Gemin2-pentamer interaction (Figure 5C) and
also fails to inhibit the pentamer’s U4 binding (Figure 5B). In
contrast, another Gemin2 mutation, R213D, which does not
affect Gemin2’s binding to the pentamer (Figure 5C), maintains
the ability to inhibit the pentamer’s RNA binding similarly to
wild-type Gemin2 (Figure 5B). The R213D mutation impairs
SMN-Gemin2 interaction (see below in Figure 6), suggesting
that SMN is not required for Gemin2 to inhibit the pentamer’s
RNA binding. However, deletion of Gemin2’s N-terminal tail up
to a1, Gemin2DN39, while maintaining the ability to bind the
Sm pentamer (Figure 5C), had little or no effect on the pentam-
er’s binding to the RNA (Figure 5A). Thus, Gemin2’s N-terminal
tail, which is inserted into the pentamer’s RNA-binding pocket,
plays an important role in preventing the Sm pentamer from
binding RNAs.
SMN-Gemin2 InteractionExplains anSMA-Causing SMN
Mutation
As shown by two different angles of the view of the structure and
with electron density map (Figures 6A and 6B), the interaction of
SMNGe2BD with Gemin2 is mediated by a single helix (SMN
residues 37–51) adjacent and antiparallel to the a2 in Gemin2’s
C-terminal domain, on the opposite side of this domain’s
SmD1/D2 binding surface (Figure 2). The SMN helix contacts
a2, a6, and a8 of Gemin2 via hydrophobic (Figure S4) and polar
interactions (Figures 6A and 6B). For example, the main-chain390 Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc.carbonyl oxygen of Ala46 and the side chain of Ser49 in SMN
form hydrogen bonds with the side chains of Gln105 and
Gln106 in Gemin2 (Figure 6A). In addition, the side chain of
Arg213 (R213) in Gemin2 forms salt bridge interactions with
that of SMN’s Asp44 (D44) (Figure 6A). This interaction is of
particular interest, as D44V mutation in SMN is an SMA-causing
patient mutation (Sun et al., 2005). To test the importance of this
interaction, we determined the effect of mutations in either R213
or D44 on full-length SMN and Gemin2 binding. As shown in
Figure 6C, D44V and D44A abrogated Gemin2 binding, consis-
tent with previous observations that also demonstrated that
SMN D44V decreases the protein’s snRNP assembly activity
(Ogawa et al., 2007). In contrast, mutation of a nearby residue
that according to the structure is not involved in SMN-Gemin2
interaction, K41A, had no effect. Reciprocally, and as expected
from the structure, mutation of R213 in Gemin2, R213D,
abrogated its binding to SMN (Figure 6D). On the other hand,
Gemin2’s Sm pentamer binding-defective mutant, Y52D (Fig-
ure 5C), showed no difference in binding to SMN (Figure 6D).
Together, these findings highlight the importance of SMN’s
D44 and Gemin2’s R213 in bridging SMN-Gemin2 interaction,
providing a structural basis of the D44V patient mutation at an
atomic resolution.
DISCUSSION
The structure and biochemical experiments provide mechanistic
insights into the process by which the SMN complex assembles
Sm cores and a structural basis for understanding the effect
of an SMA-causing SMN mutation. Sm core assembly is
Figure 6. Critical Residues Involved in
SMNGe2BD-Gemin2 Interaction and an
SMA-Causing Patient Mutation in SMN
Abrogates its Interaction with Gemin2
(A) A detailed view of the SMNGe2BD-Gemin2 polar
interactions. Ribbons are colored as in Figure 2.
Amino acid residues, side-chain carbon atoms,
oxygen and nitrogen, and potential hydrogen
bonds and salt bridges are labeled as in Figure 4.
Asp44 (D44) of SMN is mutated in an SMA patient.
Lys41 of SMN is not involved in interactions with
Gemin2 and is therefore used as a control for the
binding experiment in (C). Additional hydrophobic
interactions, involving Leu39, Tyr43, Val47, and
Phe50 in SMN interacting with a hydrophobic
pocket in Gemin2, are shown in Figure S4.
(B) Electron density map of an additional view of
the interaction regions between Gemin2 and
SMNGe2BD. SigmaA-weighted 2Fo-Fc electron
density map (gray mesh) is contoured at 1.2s. The
color schemes are the same as in (A). Protein
models are shown in cartoon representation with
contacting residues in sticks.
(C) The SMA patient mutation, D44V, abrogates SMN-Gemin2 interaction. In vitro-translated [35S]-Met-labeled wild-type SMN and the indicated mutant proteins
were incubated with recombinant GST-Gemin2. SMNDN51 lacks the Gemin2 binding domain (Wang and Dreyfuss, 2001) and is used as a negative control. The
total panel shows 5% of the proteins used for the binding.
(D) Reciprocal binding reactions were performed as in (C). In vitro-translated [35S]-Met-labeled wild-type Gemin2 or mutants (Y52D and R213D) were incubated
with recombinant GST-SMN that was immobilized on beads.
See also Figure S4.a remarkable architectural feat requiring the seven Sm proteins
to be brought together and form a ring around the pre-snRNAs’
Sm site, a short nucleotide sequence present also in numerous
other RNAs (Wahl et al., 2009; Will and Lu¨hrmann, 2001). To
accomplish this, the SMN complex must gather the Sm proteins
and inhibit their propensity for illicit Sm core assembly on unin-
tended RNAs until a pre-snRNA joins (Neuenkirchen et al.,
2008; Yong et al., 2004b). Our findings demonstrate that Gemin2
serves as the arm of the SMNcomplex that gathers five out of the
seven Sm proteins, holding them as a pentamer poised for Sm
core assembly and at the same time preventing them from
binding RNAs. The structure explains how this is accomplished,
revealing Gemin2 to be a key factor in snRNP biogenesis.
Gemin2, through its extended conformation and remarkably
extensive interactions with all five Sm proteins, grips the pen-
tamer from its bottom and top sides, and from its outer param-
eter and inner pocket. Though its specific function was not previ-
ously known, Gemin2 has been shown to have a role in Sm core
assembly (Feng et al., 2005; Ogawa et al., 2007; Shpargel and
Matera, 2005). Consistent with this, the ubiquitously expressed
Gemin2 is essential for viability of all eukaryotic organisms
(Jablonka et al., 2002; Owen et al., 2000; Paushkin et al.,
2000). Notably, Gemin2 gene deletion in the mouse causes
embryonic lethality, at an even earlier stage than SMN gene
deletion (Jablonka et al., 2002; Schrank et al., 1997). Further-
more, Gemin2’s sequence and domain structure aremore phylo-
genetically conserved than that of all other SMN complex
components, including SMN (Cauchi, 2010).
Our findings indicate that the N-terminal tail of Gemin2, partic-
ularly residues 22–31, plays a role in inhibiting the pentamer from
binding RNA as it occupies the pentamer’s RNA-binding pocket.Furthermore, several residues in this part of Gemin2, including
Met25 and Leu28 interact with the residues in the Sm proteins
that are involved in binding Sm site nucleotides and are posi-
tioned in a way that would hinder RNA binding (Figure 4D). Inter-
estingly, these residues are conserved in Gemin2 orthologs from
divergent organisms or are substituted by residues that are
compatible with having the same activity, suggesting that this
is a conserved function of Gemin2. The pentamer’s narrower
conformation in the Gemin2-bound state compared to that in
the assembled Sm core would be expected to also restrict
access of RNAs to the binding pocket. However, as the structure
of an Sm pentamer alone is unknown, it is not possible to deter-
mine whether Gemin2 binding plays a role in inducing or stabi-
lizing the narrower conformation. Recent studies have shown
that pICln, a protein that can bind Sm proteins and inhibit their
interaction with snRNA (Friesen et al., 2001b; Pesiridis et al.,
2009; Pu et al., 1999), can bind at the SmD1-G opening, forming
a closed heterohexameric ring that cannot bind snRNA (Chari
et al., 2008). A complex suggested to represent a downstream
intermediate, comprised of Drosophila C-terminal deleted
SMN, Gemin2, and the Sm pentamer, which by electron micros-
copy shows a similar overall morphology to that of our structure,
has also been described (Chari et al., 2008). Our data demon-
strate that Gemin2 can bind the Sm pentamer and prevent it
from binding snRNAs independent of pICln. Thus, there are at
least two mechanisms of pentamer inhibition that are not
incompatible and could occur sequentially, first by pICln, and
subsequently by Gemin2. However, as pICln is not obligatory
for Gemin2-pentamer association, it is also possible that the
pentamer binds directly to Gemin2, which links the pentamer
to SMN.Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc. 391
For the subsequent steps of Sm core assembly to occur, after
pre-snRNA is brought in by Gemin5, Gemin2’s N terminus,
possibly up to a1, would need to be displaced from the Sm
pentamer’s RNA-binding pocket to allow the pre-snRNA to
bind. The observation that Gemin2DN39 can bind the pentamer
suggests that such a displacement would not have the undesir-
able effect of dissociating the pentamer from the SMN complex.
The SmD1-G opening and the Sm site-binding pocket would
also need to be widened, utilizing the SmD2-F interface as
a hinge. How these structural transitions are effected remains
to be determined. Completion of Sm core assembly requires
several additional steps and ATP hydrolysis, involving additional
proteins about which little structural information is available. In
complex eukaryotes, access of RNA to the inhibited interme-
diate, comprised minimally of SMN/Gemin2-Sm pentamer, is
likely to be limited to only bona fide RNA substrates, pre-
snRNAs, delivered by Gemin5 (Yong et al., 2010). While it is clear
that SMN is oligomeric in cells (Wan et al., 2008), the number of
SMN subunits in a complex is unknown, bringing the possibility
that it serves as a scaffold for more than one Gemin2-Sm pen-
tamer forming on the same complex simultaneously. SMN deter-
mines the capacity of Sm core assembly (Wan et al., 2005), and
its oligomerization is particularly important for this function as it
serves to recruit essential components for this process.
SmB/D3 association with the SMN complex is mediated at least
in part by their direct interaction with SMN, which depends on
SMN’s oligomerization via its C-terminal YG-rich domains (resi-
dues 268–279) (Pellizzoni et al., 1999) and in which the Tudor
domain (residues 91–142) plays a role by binding to RG tails of
SmB/D3 (Brahms et al., 2001; Sprangers et al., 2003), an interac-
tion that is strongly enhanced by arginine methylation that is
carried out by the methylosome/PRMT5 (Brahms et al., 2001;
Friesen et al., 2001a, 2001b; Meister et al., 2001b). There is
evidence that an additional subunit that includes Gemins 6/7/8
andUnrip can also associate with SMN/Gemin2 and Smproteins
(Carissimi et al., 2006; Yong et al., 2010). Interestingly, Gemins 6
and 7 form a heterodimer and both have Sm folds, and it has
therefore been suggested that they might bind the pentamer in
the same position where SmB/D3 bind, potentially forming
a closed heptameric ring intermediate (Ma et al., 2005). This
could further help maintain the pentamer’s association with
SMN/Gemin2, together with Gemin8 and Unrip. The function of
Gemins 3 and 4, which exist as a dimer and associate with
Gemin5, is not known, but the presence of a DEAD box domain
in Gemin3 suggests that it may function as an RNA helicase and
may be the source of the ATPase activity on which the assembly
reaction depends. With the available structure of the key inter-
mediate we describe here, several aspects of the mechanism
and regulation of the SMN-Gemins complex as a molecular
assembly machine for snRNP biogenesis can now be readily
addressed.
The structure further explains why D44V of SMN is an SMA-
causing mutation. In the vast majority of SMA patients, the
disease results from reduced levels of the SMN protein rather
than from nonsense mutations (Wirth et al., 2006). We suggest
that D44V is a loss of function mutation because it decreases
the ability of SMN bearing this mutation to bind Gemin2 and
thus impairs the SMN complex’s capacity to recruit the Sm pen-392 Cell 146, 384–395, August 5, 2011 ª2011 Elsevier Inc.tamer for snRNP assembly. These findings thus further link
SMN’s function in snRNPbiogenesis toSMA. Further atomic level
structural information could suggest approaches to enhance
SMN-Gemin2 interaction as a potential therapy for SMA.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Protein Expression and Purification
All of the plasmids used in the studies contain human complementary DNAs
(cDNAs). Full-length SmD1 and SmD2 were constructed in a single pCDFDuet
vector (Novagen) with N-terminal His(6)-tag followed by Tobacco Etch Virus
(TEV) cleavage site (His6-Tev) fused to SmD2. Full-length SmF and SmE
were also constructed in a single pCDFDuet vector, with N-terminal His6-Tev
fused to SmE. Full-length SmG was made in pET28 vector (Novagen) with
His6-Tev at the N terminus. Full-length Gemin2 was made in pCDF vector
(Novagen) with His6-Tev at its N terminus. SMNGe2BD, containing SMN resi-
dues 26–62, was fused with an N-terminal GST tag in pET42 vector (Novagen).
Mutants of Gemin2 or SMN were created from the plasmids containing wild-
type Gemin2 or SMN cDNAs with the QuikChange site-directed mutagenesis
kit (Stratagene). SmD1/D2 was purified by Ni-column first, followed by TEV
protease cleavage, secondary pass of Ni-column, cation exchange, and gel
filtration chromatography. SmF/E and SmG were coexpressed and purified
by a similar procedure except that anion exchange was used instead. Gemin2
and SMNGe2BD were coexpressed and purified by glutathione affinity chroma-
tography, followed by TEV protease cleavage, Ni-column, and anion exchange
chromatography. To make the heptamer of the Gemin2-SMNGe2BD-Sm
pentamer complex, equal molar amount of the SmD1/D2, SmF/E/G, and
Gemin2/SMNGe2BD complexes were mixed in gel filtration buffer (20 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, and 1 mM TCEP [tris(2-carbox-
yethyl)phosphine]) supplemented with 0.5 M NaCl, and subjected to HiLoad
superdex200 gel filtration chromatography. The fractions containing all seven
components were checked by SDS-PAGE, pooled and concentrated to
7–11 mg/ml, and used for crystallization studies.
Selenomethionine (Se-Met) incorporation was performed on the subcore
complex SmF/E/G and Gemin2/SMNGe2BD by adaptation of the methionine
pathway inhibitionmethod (VanDuyne et al., 1993). Cell culture and protein puri-
fications were performed as described above, except that cells were cultured in
M9 minimal medium containing amino-acid supplement (Lys, Phe, Thr to final
concentration of 100 mg/liter, Ile, Leu, and Val to 50 mg/liter, and Se-Met to
80 mg/liter) for 15 min before protein induction with 1 mM IPTG. The Se-Met-
labeled SmF/E/G and Gemin2/SMNGe2BD were mixed with native SmD1/D2 in
equal molar stoichiometry for gel filtration as described above. The Se-Met-
labeled heptamerwas concentrated to about 8mg/ml for crystallization studies.
For GST-Gemin2 and mutant protein expression and purification, GST
fusion proteins were produced from BL21(DE3) E. coli cells containing the
expression plasmids in pGEX-4T-1 vector according to the manufacturer’s
suggestions (GE Healthcare) with few modifications (Extended Experimental
Procedures).
In Vitro Transcription and Translation of SMN and Gemin2
Various Myc-tagged SMN (wild-type, K41A, D44A, and D44V mutants) and
Gemin2 (wild-type, Y52D, and R213D mutants) constructs were in vitro tran-
scribed and translated with [35S]-Met labeling with the TNT Quick Coupled
Transcription/Translation System according to themanufacturer’s instructions
(Promega).
In Vitro Protein Binding Assays
Protein binding assays were performed according to the manufacturer’s
instructions (GE Healthcare) with few modifications (Extended Experimental
Procedures). In brief, 1 mg GST fusion proteins was immobilized on 25 ml
glutathione-Sepharose beads and incubated with 10 ml in vitro-transcribed
and -translated [35S]-Met labeled proteins in binding buffer (50 mM Tris,
200 mM NaCl, 0.2 mM EDTA, 0.05% NP-40, 2 mM DTT and protease inhibi-
tors). Bound proteins were resolved by SDS-PAGE and detected by autoradi-
ography. Alternatively, immobilized GST fusion proteins were incubated with
3 mg purified recombinant Sm proteins in buffer containing 20 mM Tris-HCl
(pH 8.0), 250 mM NaCl, 2.5 mM MgCl2, and 0.02% Triton X-100. Bound
proteins were resolved by SDS-PAGE and visualized by SimplyBlue staining
(Invitrogen).
Crystallization, Data Collection, and Structure Determination
Human Gemin2-SMNGe2BD-Sm pentamer complex crystals were grown in 1%
PEG8000, 100 mM Tris-HCl (pH 7.6–8.2) by hanging-drop vapor diffusion
method at 20C within a couple of days. They form in space group P212121,
with a = 82.8 A˚, b = 84.6 A˚, and c = 104.7 A˚. Each asymmetric unit contains
one Gemin2-SMNGe2BD-Sm pentamer complex. The crystals were cryopro-
tected by gradual transfer from reservoir solution containing 10% to 40%
PEG400, and frozen in liquid nitrogen. Se-Met-labeled complex crystals
were grown under similar conditions. The X-ray diffraction data sets of native
and Se-Met derivative complex crystals were collected at the Advanced Light
Source (ALS, Berkeley, CA) beamlines 8.2.1 and 8.2.2. Data were processed
by HKL2000 (Otwinowski and Minor, 1997). Initially, the data set obtained
from the native crystals could only be truncated to reach the maximal resolu-
tion of about 3.2 A˚. The subcore complex of SmD1/D2 inside the heptamer
complex was readily located by molecular replacement with the 2.5 A˚ crystal
structure (PDB ID code 1B34) as the search model. The components of SmF,
E, and G were located by iterative homolog model building and molecular
replacement searching in combination with SmD1/D2. Multiwavelength anom-
alous dispersion (MAD) data sets were collected at different wavelengths on
several Se-Met derivative crystals, due to severe X-ray decay of a single
crystal. Nevertheless, the best Se-Met derivative crystal data set collected
at 0.9796 A˚ was of high quality and could be used as single-wavelength anom-
alous dispersion (SAD) in combination with molecular replacement by the
SmD1/D2/F/E/G model for phase improvement by PHASER (McCoy et al.,
2007) from CCP4 suite (Potterton et al., 2003). In this way, most of the helices
of Gemin2 and SMNGe2BD were located. Since the diffraction of the crystals
was severely anisotropic, the native data set was reprocessed and truncated
ellipsoidally followed by anisoscaling (Strong et al., 2006). This extended the
resolutions to 2.4 A˚ and 2.6 A˚ in the directions of a* and c*, respectively, while
the resolution in the direction of b* still remained at 3.2 A˚. After this processing,
the resulting electron density maps for many side chains were improved. The
models were gradually improved by cycles of manual rebuilding in Coot
(Emsley and Cowtan, 2004) using combinations of methods, including density
modification, CNS simulated annealing (Bru¨nger et al., 1998), REFMAC refine-
ment (Winn et al., 2001), and PHASER molecular replacement plus SAD
(McCoy et al., 2007). Eleven Se-Met sites were found in the SAD Se-Met
data set. Eight of them were from SmF/E/G and all matched the locations of
the atoms S fromMet. Three of them were from Gemin2, which provided guid-
ance for the assignment of Gemin2 sequence. In the final stage of model
refinement, TLS followed by restrained refinement, as implemented in
REFMAC, was used. The final model (PDB ID code 3S6N) contains SmD1 (resi-
dues 1–81), SmD2 (residues 23–76 and 90–116), SmF (residues 3–76), SmE
(residues 14–90), SmG (residues 14–51 and 56–72), Gemin2 (residues
22–31, 47–69, 83–123, 134–149, and 179–276), and SMN (residues 37–51).
The higher than average Rfree of the structure model (Table 1) is due to severe
anisotropic diffraction (Strong et al., 2006) and a few regions having relatively
low-quality electron density, which cannot be confidently assigned in the
model. Ramachandran plot by MOLPROBITY (Davis et al., 2007) shows
92.3% of the dihedral angles in favored region, 6.4% in additional allowed
region, and 1.3% (seven out of 545) in disallowed region (Table 1). All of the
seven outliers are located in the loop regions with relatively poor electron
density. Only the regions supported by high quality electron density maps
are presented and discussed in detail (Figure S3 and Figure 6B).
In Vitro RNA Binding Assays
[32P]-a-UTP labeled U4 or U4DSm snRNA was produced by in vitro transcrip-
tion as previously described (Pellizzoni et al., 2002b). Binding of Smpentamers
to the radiolabeled snRNAs was performed in buffer containing 20mMHEPES
(pH 8.0), 70 mM KCl, 2.5 mM MgCl2, 0.5 mM EDTA, and 0.01% Triton X-100.
Various amounts of Sm proteins (10–50 ng of each) were used for the binding
to snRNAs. Where indicated, 1 mg recombinant Gemin2 or its deletion mutant
(Gemin2DN39) was preincubated with the Sm pentamer for 10min before RNA
was added for binding. After 30 min binding at 25C, 2M urea (final concentra-tion) was added to the reaction mixture and the RNPs were analyzed by 6%
native gel electrophoresis. For the RNA binding experiments with Gemin2 or
its mutants (Y52D and R213D), 50 ng of each Sm protein was preincubated
with various amounts of Gemin2 or the mutant proteins (1–9 mg).ACCESSION NUMBERS
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